Abstract
Due to the wide range of chemical structures and variety of mechanisms of action of antischizophrenic agents, it is difficult to identify and confirm a common pharmacophore. The present review summarizes various pharmacophore models for antischizophrenic activity including those based on the new targets, the kynurenine aminotransferase (KATs), which may facilitate the development of novel drugs. Some models illustrate the structural differences of compounds with mechanisms of action considered similar, and yet others demonstrate pharmacophore models for similar chemical classes of compounds for which the mechanism of antischizophrenic action is still not clear. In this study, we discuss the pharmacophore models for antipsychotics including phenothiazine, butyrophenone, thioxanthene, and atypical agents along with the novel antischizophrenic agents which are inhibitors of KATs isozymes.
Keywords: Antipsychotic, antischizophrenic, dopamine D2, pharmacophore, KATs inhibitors, serotonin 5-HT2A.
Medicinal Chemistry
Title:Essential Structural Features of Novel Antischizophrenic Drugs: A Review
Volume: 10 Issue: 6
Author(s): Alireza Nematollahi, Noushin Aminimoghadamfarouj and William Bret Church
Affiliation:
Keywords: Antipsychotic, antischizophrenic, dopamine D2, pharmacophore, KATs inhibitors, serotonin 5-HT2A.
Abstract: Due to the wide range of chemical structures and variety of mechanisms of action of antischizophrenic agents, it is difficult to identify and confirm a common pharmacophore. The present review summarizes various pharmacophore models for antischizophrenic activity including those based on the new targets, the kynurenine aminotransferase (KATs), which may facilitate the development of novel drugs. Some models illustrate the structural differences of compounds with mechanisms of action considered similar, and yet others demonstrate pharmacophore models for similar chemical classes of compounds for which the mechanism of antischizophrenic action is still not clear. In this study, we discuss the pharmacophore models for antipsychotics including phenothiazine, butyrophenone, thioxanthene, and atypical agents along with the novel antischizophrenic agents which are inhibitors of KATs isozymes.
Export Options
About this article
Cite this article as:
Nematollahi Alireza, Aminimoghadamfarouj Noushin and Church Bret William, Essential Structural Features of Novel Antischizophrenic Drugs: A Review, Medicinal Chemistry 2014; 10 (6) . https://dx.doi.org/10.2174/1573406410666131229150746
DOI https://dx.doi.org/10.2174/1573406410666131229150746 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Brain-to-Plasma Distribution Ratio of the Biflavone Amentoflavone in the Mouse
Drug Metabolism Letters New Trends in the Development of Positive Allosteric Modulators of AMPA Receptors
Current Medicinal Chemistry - Central Nervous System Agents CGRP Receptor Antagonists: Toward a Novel Migraine Therapy
Current Pharmaceutical Biotechnology Editorial (The 2D:4D Digit Ratio: A Biomarker of Alcohol and Drug Abuse?)
Current Drug Abuse Reviews Increasing Delta-9-Tetrahydrocannabinol (Δ-9-THC) Content in Herbal Cannabis Over Time: Systematic Review and Meta-Analysis
Current Drug Abuse Reviews The Transcriptional Regulation of the Human CYP2C Genes
Current Drug Metabolism Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part II
Inflammation & Allergy - Drug Targets (Discontinued) Mechanisms of Neuropathic Pain
Current Medicinal Chemistry - Central Nervous System Agents Recent Approaches for Studying the Role of Glia
CNS & Neurological Disorders - Drug Targets Optimizing Contrast Effect in T1-Weighted Magnetic Resonance Imaging of Gd2O3-Based Nano-Agent via Dopamine Chelation
Neuroscience and Biomedical Engineering (Discontinued) Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment
Current Neuropharmacology Radiolabeled Glucocorticoids as Molecular Probes for Imaging Brain Glucocorticoid Receptors by Means of Positron Emission Tomography (PET)
Mini-Reviews in Medicinal Chemistry Inhibitors of Monoamine Oxidase and Acetylcholinesterase as a Front Runner in CNS Drug Discovery
Combinatorial Chemistry & High Throughput Screening Spirooxindoles as Potential Pharmacophores
Mini-Reviews in Medicinal Chemistry Biomarker Discovery in Clinical Proteomics: Strategies for Exposing Low Abundant Proteins
Current Proteomics A New Target for Diagnosis and Treatment of CNS Disorders: Agmatinergic System
Current Medicinal Chemistry Editorial: Pain in Dementia: A Distressing Combination of Several Factors
Current Alzheimer Research Are the Long-Acting Intramuscular Formulations of Risperidone or Paliperidone Palmitate Associated with Post-Injection Delirium/Sedation Syndrome? An Assessment of Safety Databases
Current Drug Safety Alzheimers Disease and n-3 Polyunsaturated Fatty Acids: Beneficial Effects and Possible Molecular Pathways Involved
Current Signal Transduction Therapy The Complex Inter-Relationship Between Diabetes and Schizophrenia
Current Diabetes Reviews